Pune: While speaking on 67 cases of Guillain-Barre Syndrome (GBS) reported in Pune district, Assistant Health Officer, Pune Municipal Corporation Vaishali Jadhav said that a total of 67 cases of ...

Three cases of Human Metapneumovirus (HMPV) have been detected in India - two in Bengaluru and one in Ahmedabad. The cases were detected in babies and one of them has been discharged from the ...

NEW DELHI: India’s apex drug regulator has turned down a proposal by Serum Institute of India to test the Covid-19 vaccine Covovax on children, saying it needs to evaluate safety and ...

The Drugs Controller General of India (DCGI) on Tuesday approved Serum Institute of India's Covovax Covid-19 vaccine for restricted emergency use children aged 7-11 years, ANI reported. The DCGI had ...

New Delhi: The subject expert committee on COVID-19 of India's drug regulator will on Friday review the applications of Serum Institute of India seeking emergency use authorisation to use Covovax ...

Coronavirus vaccine Covovax is now available for children in India, Serum Institute of India's CEO Adar Poonawalla said on May 3. Covovax is the only vaccine manufactured in India that is also ...

Children aged 12 to 17 years can now get the Serum Institute’s coronavirus vaccine Covovax at private centres with a provision for it being made on the CoWIN portal, official sources said on Monday.

NEW DELHI: The National Technical Advisory Group on Immunization (NTAGI) has approved the Serum Institute’s Covid-19 Covovax for the 12-17 age group. But, no decision has been taken on ...

A Covid working group of NTAGI will review this week data of Serum Institute of India's (SII) anti-coronavirus jab Covovax to decide whether it can be included in the national COVID-19 vaccination ...

The Drugs Controller General of India (DCGI) has granted emergency use authorisation (EUA) for the Novavax and Serum Institute of India (SII) Covid-19 vaccine, Covovax, in the 12-18 age group.

New Delhi: The Drugs Controller General of India (DCGI) granted permission on Wednesday for conducting the phase-3 clinical trial of Covid-19 vaccine Covovax as a booster dose in adults ...

India's drug regulator has granted restricted emergency use authorisation to Serum Institute of India's COVID-19 vaccine Covovax for the 12-17 years age group subject to certain conditions, official ...